pharmaphorum
APRIL 14, 2021
More than 5,000 collaborative studies were thwarted by GDPR rules in 2019 – but is there a way to protect sensitive data while still allowing international health research to thrive? . A coalition of European academy networks has called upon European Union (EU) leaders to rethink how General Data Protection Regulation (GDPR) rules are applied to health data.
NY Times
APRIL 15, 2021
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
APRIL 12, 2021
The 2021 Clinical Researcher of the Year – The Americas competition is reaching out to the very best in the industry to take the next step and claim gold.
Outsourcing Pharma
APRIL 15, 2021
The science service and technologies firm plans to bring the CRO under its Laboratory Products and Services Segment umbrella after the deal is completed.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
APRIL 12, 2021
A scheduled update to the NHS COVID-19 app has been blocked because it allows location tracking – something prohibited by Apple and Google, which developed some of the code it uses. . The new version of the app used in England and Wales was due to become available today to coincide with the relaxation of lockdown rules, with the public now able to attend venues such as non-essential shops, pub beer garden, gyms and hairdressers.
Pharma Marketing Network
APRIL 15, 2021
Over the last year, we witnessed a massive shift to digital technologies in the health industry – trends that were gradually making their ways suddenly moved into prompt adoption due to the immense limitations brought by the COVID-19 pandemic. Download this infographic and learn which 6 digital tools are at the center of digitalization and how the will influence the future of Pharma marketing in 2021 and beyond.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
NY Times
APRIL 15, 2021
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
pharmaphorum
APRIL 12, 2021
Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society – especially in healthcare. Page & Page’s Lisa Jane Lishman outlines why communication and the strategies behind it need to be more personal to ensure that people – whoever they are – feel valued and respected.
Pharma Marketing Network
APRIL 13, 2021
This content is password protected. To view it please enter your password below: Password: The post Protected: Health Psychology – the Solution to First Fill Abandonment? appeared first on Pharma Marketing Network.
Pharma Times
APRIL 15, 2021
Researchers from Imperial College London say compound is at least as effective as a leading antidepressant in a therapeutic setting
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
APRIL 14, 2021
The drug-discovery firm has partnered with several academic institutions to explore a Novartis lung-cancer treatmentâs potential in treating COVID-19.
pharmaphorum
APRIL 12, 2021
Exscientia was the first company to start human trials of a new drug designed using artificial intelligence (AI) last year, and now says it has started testing of the first AI candidate for immuno-oncology. . Oxford, UK-based Exscientia has been working with German biotech Evotec on the adenosine A2a receptor antagonist, which is being tested as a treatment for adult patients with advanced solid tumours.
NY Times
APRIL 13, 2021
The agency said it would stop enforcing a rule requiring women to get the first of two pills in person at a medical clinic or hospital.
Pharma Times
APRIL 14, 2021
Dosing has begun in a Phase III study evaluating the contraceptive efficacy of relugolix combination tablet
Outsourcing Pharma
APRIL 12, 2021
Leaders from the supply chain solutions company share their thoughts on challenges associated with virtual and hybrid trials, and the COVID-19 pandemic.
pharmaphorum
APRIL 16, 2021
The active compound in magic mushrooms – psilocybin – seems to be at least as effective as a commercially-available antidepressant in a phase 2 trial, and may work more quickly. . Researchers at Imperial College London’s Centre for Psychedelic Research also say that psilocybin may have a stronger effect and was more likely to help patients achieve remission from depression, although they stress the study was small and more research is needed.
NY Times
APRIL 13, 2021
The agency said it would stop enforcing a rule requiring women to get the first of two pills in person at a medical clinic or hospital.
Pharma Times
APRIL 13, 2021
Self-reported recovery was three days shorter for patients receiving inhaled budesonide
Outsourcing Pharma
APRIL 13, 2021
The two companies have partnered to develop a systemic erythematosus assessment review to streamline clinical trials centered on the autoimmune disease.
pharmaphorum
APRIL 16, 2021
A study has suggested that the risk of getting a serious brain clot is eight to 10 times higher in people with COVID-19 than those who get a vaccine. There are some big caveats with the research from Oxford University – it was based on data from people in the US who had received either a Pfizer or Moderna vaccine – but the team said findings could reassure people about the safety of vaccines.
Pharma Marketing Network
APRIL 12, 2021
Native advertising may mean something different to you depending on what part of the industry you’re in whether it be in advertising or publishing. . Tune in and listen to the Pharma Marketing Network and fellow thought leaders from, ROI Marketplace, MedThink, and Sharecare.com, discuss their learnings and insights on native advertising from each of their respective vantage points – pharma-marketer, publisher, and agency. .
Pharma Times
APRIL 16, 2021
Multiple sclerosis treatment can now be administered subcutaneously or intravenously
Outsourcing Pharma
APRIL 13, 2021
A leader from the trial tech firm says COVID-19 has accelerated virtual studies, creating opportunities to improve patient engagement, costs and data.
pharmaphorum
APRIL 14, 2021
A phase 3 trial of Romark’s antiviral drug NT-300 has missed the main objective in a phase 3 trial in mild to moderate COVID-19 patients, but could still have a shot at emergency use authorisation (EUA), according to the US company. . The Florida-based firm has just released top-line results from the 1,092-patient study , showing that patients treated NT-300 – an orally-active, long-acting formulation of the established drug nitazoxanide – didn’t differ significantly from a placebo group i
NY Times
APRIL 13, 2021
Confusion over AstraZeneca’s vaccine threatens to hurt the E.U. campaign just as it gathers momentum. And on Tuesday, Johnson & Johnson said it was pausing the rollout of its shot on the continent.
Pharma Times
APRIL 14, 2021
US Food and Drug Administration approved antibody drug conjugate based on Phase II trial results
Drug Patent Watch
APRIL 16, 2021
Annual Drug Patent Expirations for AKYNZEO Akynzeo is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from one supplier. There are seventeen patents…. The post New patent for Helsinn Hlthcare drug AKYNZEO appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
APRIL 13, 2021
Whether present in electronic or combustible cigarettes, nicotine is a highly addictive substance. Dr Cindy Jacobs, chief medical officer of Achieve Life Sciences discusses the potential of cytisinicline therapy for smoking cessation. . Although e-cigarettes are considered a less dangerous alternative to combustible cigarettes, they can still result in, or sustain, nicotine addiction, for which the long-term safety issues and associated health risks are unknown.
NY Times
APRIL 14, 2021
After an early focus on AstraZeneca and months of turmoil, the European Union is pivoting away from the company’s vaccine. It has reached agreement for a faster rollout of the Pfizer-BioNTech shot.
Pharma Times
APRIL 13, 2021
Newly accepted medicines include treatments for multiple myeloma and severe migraine
Drug Patent Watch
APRIL 16, 2021
Annual Drug Patent Expirations for FIRVANQ+KIT Firvanq Kit is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are two patents…. The post New patent for Azurity drug FIRVANQ KIT appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
APRIL 15, 2021
The Czech Republic wants to buy around 2.4 million doses of the AstraZeneca/Oxford University vaccine ditched by Denmark, which has said it will stop using it because of concerns about rare blood clotting side-effects. Czech deputy prime minister Jan Hamacek said on twitter that he had instructed the country’s ambassador in Denmark to try to buy the unwanted doses.
Pharma Mirror
APRIL 16, 2021
Running a healthcare business is a tricky thing. Certain equipment is often being requested by physicians who are insisting it’s needed to improve patient diagnosis and care. Yet, it’s not always affordable. Other times, it’s preferred, but the business should be mindful of the cost and look at how best to afford it. Should medical equipment be purchased outright, leased, and then acquired or delayed until it’s more affordable?
Pharma Times
APRIL 15, 2021
The funding will be used to advance Alchemab’s novel platform to identify disease-modifying antibody therapeutics
Drug Patent Watch
APRIL 16, 2021
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-one…. The post New patent for Astrazeneca Ab drug BYDUREON BCISE appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
141 
Let's personalize your content